Compare UNB & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UNB | PYPD |
|---|---|---|
| Founded | 1891 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.4M | 85.1M |
| IPO Year | 1999 | 2014 |
| Metric | UNB | PYPD |
|---|---|---|
| Price | $23.26 | $4.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $12.25 |
| AVG Volume (30 Days) | 20.2K | ★ 151.7K |
| Earning Date | 04-15-2026 | 05-06-2026 |
| Dividend Yield | ★ 5.76% | N/A |
| EPS Growth | ★ 25.52 | N/A |
| EPS | ★ 0.65 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $35.46 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $20.65 | $2.79 |
| 52 Week High | $29.49 | $5.21 |
| Indicator | UNB | PYPD |
|---|---|---|
| Relative Strength Index (RSI) | 43.63 | 45.50 |
| Support Level | $23.06 | $4.15 |
| Resistance Level | $24.77 | $4.56 |
| Average True Range (ATR) | 0.53 | 0.28 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 23.19 | 1.41 |
Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The Company has one definable business segment, Union Bank, which provides full retail, commercial, municipal banking, and wealth management and trust services throughout its 18 branch banking locations, three loan centers, and several ATMs covering northern Vermont and northern New Hampshire. In addition, it also offers fiduciary and asset management services through its Asset Management Group.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.